Clinical Trials Directory

Trials / Completed

CompletedNCT00575354

Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor Excision

Anesthesia With Sevoflurane and Isoflurane for Excision Surgeries in Benign Breast Tumors

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
500 (actual)
Sponsor
Nanjing Medical University · Academic / Other
Sex
Female
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

Generally, benign breast tumors are excised under the local anesthesia. But such action was so invasive that every patient would experience the physiological and psychological stimuli unavoidably. Sevoflurane was advised as a better inhalational anesthesic for its "easy come,easy go" property during short-lasting operations than isoflurane. We purposed that sevoflurane would be a superior anesthesic for benign breast tumor excision than isoflurane with relative less alteration in hemodynamics, less postoperative side effects and easily-control the depth of anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGSevoflurane3-6% sevoflurane inhaled for anesthesia induction, and 2-3% sevoflurane was used to maintain the anesthesia till the end of the operation.
DRUGIsoflurane3-6% isoflurane inhaled for anesthesia induction, and 2-3% isoflurane was used to maintain the anesthesia till the end of the operation.

Timeline

Start date
2007-03-01
Primary completion
2007-12-01
Completion
2007-12-01
First posted
2007-12-18
Last updated
2008-04-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00575354. Inclusion in this directory is not an endorsement.